2009 European Patient Monitoring Technology Leadership of the Year given to Mennen Medical Award Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, announced today that the global development consulting company Frost & Sullivan has awarded Mennen Medical the 2009 2009 European Patient Monitoring Technology Leadership of the Year Award. This prestigious award is bestowed upon the ongoing company that has demonstrated excellence in technology leadership within their industry. Frost & Sullivan shown the ‘2009 European Patient Monitoring Technology Leadership of the entire year Award’ to Mennen Medical because of its innovative and advanced technical platform – the CIPAM, which is being used by Mennen Medical in its patient monitors and hemodynamic applications suhagra 100 reviews .
Highlighting the low number of cancer-related deaths (4.4 vs 31. All privileges reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.. 21st century trends in management of small renal cancers By Shreeya Nanda, Senior medwireNews Reporter A US population-based cohort research reveals a switch in the management of small renal masses in the 21st century with rates of nephron-sparing surgery increasing and a corresponding reduction in the usage of radical nephrectomy.0 percent were treated surgically. During the research period, the proportion of patients receiving nephron-sparing surgery, comprising partial ablation and nephrectomy, increased from 21.5 percent to 49.0 percent.